Immucell OverviewImmucell Operating Income
Operating Income for ICCC.
Quarterly Operating Income
$1.97M
↓ 99.82% YoY
As of Mar 31, 2026
Annual Operating Income (TTM)
$2.50M
↓ 99.54% YoY
Trailing 12 months ending Mar 31, 2026
Immucell OverviewOperating Income for ICCC.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026